The National Institutes of Health wants to know how critical race theory can be applied to prescriptions that address opioid addiction.
The University of Washington study, “Applying Critical Race Theory to investigate the impact of COVID-19-related policy changes on racial/ethnic disparities in medication treatment for opioid use disorder,” hopes to “inform future policy and interventions to improve equitable care for [Opioid Use Disorder],” according to the proposal.
The study is set to end in 2027. The NIH allocated $558,942 to the research.
The project is led by Emily Williams, a health professor at UW. According to her faculty bio, she is an “addictions health services and disparities researcher and an implementation scientist.” Assistant Professor Jessica Ann Chen, a clinical psychologist, is also working on the study.